Definition of Complicated Urinary Tract Infection
A complicated UTI occurs when a patient has host-related factors or specific anatomic/functional abnormalities in the urinary tract that make the infection more challenging to eradicate compared to an uncomplicated infection. 1
Core Defining Features
The 2024 European Association of Urology guidelines provide the most current framework for identifying complicated UTIs, emphasizing that these infections encompass a heterogeneous patient population requiring individualized assessment rather than a one-size-fits-all approach. 1
Host-Related and Anatomic Factors
The following factors classify a UTI as complicated: 1
Structural/Anatomic Abnormalities:
- Obstruction at any site in the urinary tract 1
- Foreign body presence (including catheters) 1
- Incomplete voiding 1
- Vesicoureteral reflux 1
Patient-Specific Factors:
Healthcare and Resistance-Related:
- Recent history of instrumentation 1
- Healthcare-associated infections 1
- ESBL-producing organisms isolated 1
- Multidrug-resistant organisms isolated 1
Clinical Implications
The microbial spectrum in complicated UTIs is broader than uncomplicated infections, with significantly higher antimicrobial resistance rates. 1 Common pathogens include E. coli, Proteus spp., Klebsiella spp., Pseudomonas spp., Serratia spp., and Enterococcus spp. 1
Important Caveats
The term "complicated UTI" lacks a standardized clinical definition across guidelines and literature, creating diagnostic ambiguity. 2 The WikiGuidelines consensus (2024) strongly encourages using more precise clinical descriptions rather than vague terminology like "complicated" or "uncomplicated." 2
A critical distinction: Complicated UTI may involve systemic symptoms (fever, flank pain) suggesting pyelonephritis, or may present with only lower urinary tract symptoms in the presence of complicating factors. 2 The presence of complicating factors—not symptom severity alone—determines the classification. 1
Management Principles
Appropriate management of the underlying urological abnormality or complicating factor is mandatory for successful treatment. 1 Urine culture and susceptibility testing should always be performed before initiating empirical therapy. 1
Treatment duration typically ranges from 7-14 days (14 days for men when prostatitis cannot be excluded), though this should be closely related to treatment of the underlying abnormality. 1 Shorter 7-day courses may be considered when patients are hemodynamically stable and afebrile for at least 48 hours. 1